Gravar-mail: Pilot Study Using Post-transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation